5-Amino-1MQ vs Thymosin Alpha-1
5-Amino-1MQ and Thymosin Alpha-1 are studied in overlapping research areas, which is why they are frequently compared. This is a neutral side-by-side reference drawn from published preclinical literature and laboratory handling data.
How they actually differ
Comparing the two: 5-Amino-1MQ is small-molecule nnmt inhibitor (methylquinolinium salt) — not a peptide, while Thymosin Alpha-1 is n-acetylated 28-residue thymic peptide — different molecular classes with different handling consequences; their leading degradation routes differ (microbial growth in non-preserved diluent for 5-Amino-1MQ, deamidation and aspartate isomerisation in this asn/asp-rich sequence for Thymosin Alpha-1), so the storage precautions that matter are not the same; their practical working windows differ once reconstituted. The sections below set out each in full.
5-Amino-1MQ — origin
5-Amino-1MQ is a small quinolinium molecule characterised as a first-in-class inhibitor of NNMT (nicotinamide N-methyltransferase), an enzyme studied at the intersection of adipocyte metabolism and the cellular NAD+/methylation pool. It is not an amino-acid chain, which is why it sits apart from every peptide in this catalogue.
Thymosin Alpha-1 — origin
Thymosin Alpha-1 is an N-terminally acetylated 28-amino-acid peptide derived from prothymosin alpha and originally isolated from thymic tissue. It is one of the most-studied immune-modulating peptides, examined for a role in T-cell maturation and immune signalling; the clinical formulation is known as Zadaxin.
5-Amino-1MQ research themes
The defining mechanism — preclinical work has examined how blocking NNMT shifts methylation flux and NAD+ salvage in metabolic tissue models.
Studied in fat-cell models for effects on cellular energy handling and lipid metabolism.
Because NNMT consumes a methyl group tied to the NAD+ precursor pool, it is studied alongside the wider NAD+ research field.
Thymosin Alpha-1 research themes
Studied for a role in the maturation and function of T-cells in immune research models.
Examined around innate immune signalling pathways, including Toll-like-receptor involvement, in preclinical work.
Investigated in models of immune response to infection and as a research adjuvant.
5-Amino-1MQ handling
- Let the sealed vial reach room temperature before opening so moisture does not condense onto the powder.
- For cell-based assays, prepare a concentrated DMSO stock and dilute into aqueous buffer rather than dissolving directly at high concentration in medium.
- Label aliquots with reconstitution date and diluent.
Thymosin Alpha-1 handling
- Reach room temperature before opening.
- Swirl to dissolve; the disordered peptide clears quickly.
- Label aliquots with reconstitution date and diluent.
Both third-party tested
Every Popular Peptides batch of 5-Amino-1MQ and Thymosin Alpha-1 is independently tested by HPLC and LC-MS with a published Certificate of Analysis. Enter a lot number to pull the COA for a specific vial.
5-Amino-1MQ reference
Related comparisons
5-Amino-1MQ and Thymosin Alpha-1 are supplied strictly as research chemicals for in-vitro laboratory and research use only. They are not intended for human or animal consumption, diagnostic, or therapeutic use. This comparison summarizes published preclinical literature and laboratory handling data; it is not medical advice, not a claim of efficacy, and not usage guidance.